Triple-A syndrome: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Triple-A syndrome | |||
| image = [[File:1471-2415-4-7-1-l.jpg|alt=Image of a patient with Triple-A syndrome]] | |||
| caption = A patient with Triple-A syndrome | |||
| synonyms = [[Allgrove syndrome]], [[AAA syndrome]] | |||
| pronounce = | |||
| specialty = [[Endocrinology]], [[Neurology]], [[Genetics]] | |||
| symptoms = [[Achalasia]], [[Adrenal insufficiency]], [[Alacrima]] | |||
| onset = Childhood | |||
| duration = Lifelong | |||
| causes = Mutations in the [[AAAS gene]] | |||
| risks = | |||
| diagnosis = Clinical evaluation, genetic testing | |||
| differential = [[Addison's disease]], [[Esophageal motility disorder]] | |||
| prevention = None | |||
| treatment = [[Hormone replacement therapy]], [[Botulinum toxin]] for achalasia | |||
| medication = [[Glucocorticoids]], [[Mineralocorticoids]] | |||
| prognosis = Variable, depends on severity and management | |||
| frequency = Rare | |||
| deaths = | |||
}} | |||
{{Short description|A rare autosomal recessive disorder}} | {{Short description|A rare autosomal recessive disorder}} | ||
'''Triple-A syndrome''', also known as '''Allgrove syndrome''', is a rare [[autosomal recessive]] disorder characterized by the triad of [[achalasia]], [[adrenal insufficiency]], and [[alacrima]]. The condition is caused by mutations in the AAAS gene, which encodes the protein ALADIN, involved in nuclear pore complex function. | '''Triple-A syndrome''', also known as '''Allgrove syndrome''', is a rare [[autosomal recessive]] disorder characterized by the triad of [[achalasia]], [[adrenal insufficiency]], and [[alacrima]]. The condition is caused by mutations in the AAAS gene, which encodes the protein ALADIN, involved in nuclear pore complex function. | ||
==Signs and symptoms== | ==Signs and symptoms== | ||
The hallmark features of Triple-A syndrome include: | The hallmark features of Triple-A syndrome include: | ||
* '''Achalasia''': A condition where the lower esophageal sphincter fails to relax properly, leading to difficulty swallowing (dysphagia), regurgitation, and sometimes chest pain. | * '''Achalasia''': A condition where the lower esophageal sphincter fails to relax properly, leading to difficulty swallowing (dysphagia), regurgitation, and sometimes chest pain. | ||
* '''Adrenal insufficiency''': This results from the underproduction of adrenal hormones, particularly cortisol, leading to symptoms such as fatigue, muscle weakness, weight loss, low blood pressure, and hyperpigmentation of the skin. | * '''Adrenal insufficiency''': This results from the underproduction of adrenal hormones, particularly cortisol, leading to symptoms such as fatigue, muscle weakness, weight loss, low blood pressure, and hyperpigmentation of the skin. | ||
* '''Alacrima''': A lack of tear production, which can lead to dry eyes and increased risk of eye infections. | * '''Alacrima''': A lack of tear production, which can lead to dry eyes and increased risk of eye infections. | ||
Additional symptoms may include neurological abnormalities, such as peripheral neuropathy, autonomic dysfunction, and cognitive impairment. | Additional symptoms may include neurological abnormalities, such as peripheral neuropathy, autonomic dysfunction, and cognitive impairment. | ||
==Genetics== | ==Genetics== | ||
Triple-A syndrome is inherited in an [[autosomal recessive]] pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The AAAS gene is located on chromosome 12q13, and mutations in this gene disrupt the function of the ALADIN protein, affecting cellular processes. | Triple-A syndrome is inherited in an [[autosomal recessive]] pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The AAAS gene is located on chromosome 12q13, and mutations in this gene disrupt the function of the ALADIN protein, affecting cellular processes. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of Triple-A syndrome is based on clinical evaluation, family history, and genetic testing. The presence of the characteristic triad of symptoms often prompts further investigation. Genetic testing can confirm mutations in the AAAS gene. | Diagnosis of Triple-A syndrome is based on clinical evaluation, family history, and genetic testing. The presence of the characteristic triad of symptoms often prompts further investigation. Genetic testing can confirm mutations in the AAAS gene. | ||
==Management== | ==Management== | ||
Management of Triple-A syndrome is symptomatic and supportive. Treatment may include: | Management of Triple-A syndrome is symptomatic and supportive. Treatment may include: | ||
* Hormone replacement therapy for adrenal insufficiency, typically with glucocorticoids and mineralocorticoids. | * Hormone replacement therapy for adrenal insufficiency, typically with glucocorticoids and mineralocorticoids. | ||
* Surgical or endoscopic intervention for achalasia, such as pneumatic dilation or Heller myotomy. | * Surgical or endoscopic intervention for achalasia, such as pneumatic dilation or Heller myotomy. | ||
* Artificial tears and other measures to manage alacrima and protect the eyes. | * Artificial tears and other measures to manage alacrima and protect the eyes. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with Triple-A syndrome varies depending on the severity of symptoms and the effectiveness of treatment. With appropriate management, many individuals can lead relatively normal lives, although they may require ongoing medical care. | The prognosis for individuals with Triple-A syndrome varies depending on the severity of symptoms and the effectiveness of treatment. With appropriate management, many individuals can lead relatively normal lives, although they may require ongoing medical care. | ||
==See also== | |||
== | |||
* [[Achalasia]] | * [[Achalasia]] | ||
* [[Adrenal insufficiency]] | * [[Adrenal insufficiency]] | ||
* [[Autosomal recessive disorder]] | * [[Autosomal recessive disorder]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
Latest revision as of 19:21, 8 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Triple-A syndrome | |
|---|---|
| |
| Synonyms | Allgrove syndrome, AAA syndrome |
| Pronounce | |
| Specialty | Endocrinology, Neurology, Genetics |
| Symptoms | Achalasia, Adrenal insufficiency, Alacrima |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the AAAS gene |
| Risks | |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | Addison's disease, Esophageal motility disorder |
| Prevention | None |
| Treatment | Hormone replacement therapy, Botulinum toxin for achalasia |
| Medication | Glucocorticoids, Mineralocorticoids |
| Prognosis | Variable, depends on severity and management |
| Frequency | Rare |
| Deaths | |
A rare autosomal recessive disorder
Triple-A syndrome, also known as Allgrove syndrome, is a rare autosomal recessive disorder characterized by the triad of achalasia, adrenal insufficiency, and alacrima. The condition is caused by mutations in the AAAS gene, which encodes the protein ALADIN, involved in nuclear pore complex function.
Signs and symptoms[edit]
The hallmark features of Triple-A syndrome include:
- Achalasia: A condition where the lower esophageal sphincter fails to relax properly, leading to difficulty swallowing (dysphagia), regurgitation, and sometimes chest pain.
- Adrenal insufficiency: This results from the underproduction of adrenal hormones, particularly cortisol, leading to symptoms such as fatigue, muscle weakness, weight loss, low blood pressure, and hyperpigmentation of the skin.
- Alacrima: A lack of tear production, which can lead to dry eyes and increased risk of eye infections.
Additional symptoms may include neurological abnormalities, such as peripheral neuropathy, autonomic dysfunction, and cognitive impairment.
Genetics[edit]
Triple-A syndrome is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The AAAS gene is located on chromosome 12q13, and mutations in this gene disrupt the function of the ALADIN protein, affecting cellular processes.
Diagnosis[edit]
Diagnosis of Triple-A syndrome is based on clinical evaluation, family history, and genetic testing. The presence of the characteristic triad of symptoms often prompts further investigation. Genetic testing can confirm mutations in the AAAS gene.
Management[edit]
Management of Triple-A syndrome is symptomatic and supportive. Treatment may include:
- Hormone replacement therapy for adrenal insufficiency, typically with glucocorticoids and mineralocorticoids.
- Surgical or endoscopic intervention for achalasia, such as pneumatic dilation or Heller myotomy.
- Artificial tears and other measures to manage alacrima and protect the eyes.
Prognosis[edit]
The prognosis for individuals with Triple-A syndrome varies depending on the severity of symptoms and the effectiveness of treatment. With appropriate management, many individuals can lead relatively normal lives, although they may require ongoing medical care.
